Condition
CGM
ClinicalTrials.gov condition label
Advertisement
Clinical trials
7 shownEvaluate the Performance of the Dexcom G7 Continuous Glucose Monitoring (CGM) System in Critically Ill Patients Undergoing Major Abdominal Surgery and Solid Organ Transplantation Which Require Blood Glucose Monitoring for Intensive Insulin Therapy.NCT07611721 · 2026-01-14
RECRUITINGTransition to Hospital Discharge in Insulinized Patients With Type 2 Diabetes MellitusNCT07061301 · 2024-08-01
RECRUITINGEfficacy of the Use of Real-time Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes and Stage 3 and 4 Chronic Kidney Disease.NCT07668219 · 2026-11-01
NOT_YET_RECRUITINGAutomated Insulin Delivery Versus Daily Injections for Hospital Diabetes CareNCT07645079 · 2026-07-01
NOT_YET_RECRUITINGEvaluation of Physician-based Decision SupportNCT03443713 · 2018-07-18
COMPLETEDEstablishing Ambulatory Glucose Profiles for People Without Diabetes Using CGM DataNCT00467675 · 2006-04-01
COMPLETEDDevelop Novel Methods to Display, Report and Analyze CGM Data for Clinical Decision-Making in People With DiabetesNCT00465881 · 2006-01-01
COMPLETEDCommon interventions
CGM System for Type 1 and Type 2 Diabetes MellitusDEVICE2automated insulin delivery systemDEVICE1Continuous glucose monitorDEVICE1Control-armPROCEDURE1Dexcom G6 CGMDEVICE1GlucoTabPROCEDURE1Real time continuos glucose monitoringDEVICE1self blood glucose monitoringDEVICE1Technological groupDEVICE1Usual Care groupDEVICE1
Leading sponsors
Trial status mix
COMPLETED3
NOT_YET_RECRUITING2
RECRUITING2
Phase mix
NA5
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.